Status:
COMPLETED
Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Shivering
Nausea and Vomiting, Postoperative
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This is a randomized double blinded trial to determine if a small dose of dexmedetomidine can prevent and relieve nausea and shivering, two of the more common complaints after cesarean delivery.
Detailed Description
This study is a randomized, placebo controlled, double blind evaluation of the use of a single dose of dexmedetomidine for the prevention of shivering and nausea after cesarean delivery. It is hypothe...
Eligibility Criteria
Inclusion
- Elective cesarean delivery
- ≥ 18 years of age
- Singleton pregnancy
- Term delivery (37 weeks or greater gestation)
- Spinal or combined spinal-epidural anesthesia is planned
Exclusion
- Non-elective cesarean delivery
- Receiving misoprostil or carboprost
- Postpartum hemorrhage greater that 1000cc
- Chronic opioid use
- History of chronic nausea or itching in pregnancy
- Receiving medications for nausea
- Inability to provide written informed consent
- Receiving of any of the following medications intraoperatively: misoprostil, carboprost, medications for nausea
- Postpartum hemorrhage greater that 1000cc
Key Trial Info
Start Date :
February 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03370562
Start Date
February 18 2020
End Date
December 31 2020
Last Update
October 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215